Status:
COMPLETED
Electronic Repositioning With Acuity and Easytrak Leads
Lead Sponsor:
Boston Scientific Corporation
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Evaluate appropriate performance of Electronic Repositioning™ (ER) in the clinical routine, cumulative incidence of phrenic nerve stimulation (PNS) \& success rates of Electronic Repositioning (ER) to...
Detailed Description
Bipolar leads for left ventricular pacing (LVP) such as the newly available ACUITY™ or the standard EASYTRAK™ II and EASYTRAK™ III leads from GUIDANT in combination with suitable devices for cardiac r...
Eligibility Criteria
Inclusion
- Patients receiving their FIRST implantation of a Left Ventricular (LV) lead in combination with a CRT device with implantable cardioverter defibrillator (ICD) backup and the possibility for Electronic Repositioning™
- Patients willing (= signed written consent) and capable to participate in all procedures of the study"
Exclusion
- Patients who will not be available for routine Follow up
- 18 years old
- Known pregnancy.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
305 Patients enrolled
Trial Details
Trial ID
NCT00610116
Start Date
September 1 2006
End Date
September 1 2008
Last Update
April 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Düsseldorf, Germany, 40225